Login / Signup

Drug Exposure of Long-Acting Cabotegravir and Rilpivirine in Older People With Human Immunodeficiency Virus: A Pharmacokinetic Modeling Study.

Sara BettonteMattia BertonFelix StaderManuel BattegayCatia Marzolini
Published in: Open forum infectious diseases (2024)
LA cabotegravir/rilpivirine exposure and trough concentrations are predicted to be higher in older than in young PWH; thus, older adults could have a lower risk to present suboptimal concentrations during the dosing interval.
Keyphrases
  • human immunodeficiency virus
  • middle aged
  • physical activity
  • antiretroviral therapy
  • hepatitis c virus
  • hiv infected patients
  • community dwelling
  • hiv infected
  • hiv positive
  • hiv aids
  • adverse drug